Oklo Inc. announced on March 5, 2025, that it has closed the acquisition of Atomic Alchemy Inc., a leading innovator in radioisotope production. The acquisition was completed on February 28, 2025, for $25 million in an all-stock transaction.
Atomic Alchemy will now operate as an Oklo subsidiary, pioneering a resilient U.S.-based radioisotope supply chain with its proprietary production and recovery technologies, including its Versatile Isotope Production Reactor (VIPR®) technology. This enhances Oklo’s capabilities to establish a domestic supply for critical radioisotopes.
The radioisotope market is projected to represent a $55.7 billion opportunity by 2026, with demand expected to increase significantly. Oklo aims to address this growing market demand through reliable, U.S.-based production facilities that leverage its nuclear reactor and fuel recycling technologies. The acquisition is expected to have minimal immediate impact on Oklo’s operating costs and 2025 outlook.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.